Hairy Cell Leukemia


Pass It On: July is National Leukemia and Lymphoma Awareness Month (September 1, 2016)

Leukemia and lymphoma are both hematologic malignancies, meaning that they involve the blood or bone marrow. The American Cancer Society (ACS) estimates that there will be 60,140 new cases of leukemia... Continue Reading

Ask the Expert: Blood Cancer Treatment Progress & What’s Next (October 7, 2015)

CancerConnect Presents: Ask the Expert: Blood Cancer Treatment Progress & What’s Next In this informative web chat, Jacqueline Barrientos, MD discusses blood cancer prevalence, evolution of blood... Continue Reading

Zelboraf® Appears Active in Hairy Cell Leukemia That Has Progressed After Other Treatment (October 7, 2015)

The medication Zelboraf® (vemurafenib) appears active in the treatment of hairy cell leukemia (HCL) that had progressed after previous therapy. These findings were published in New England Journal of... Continue Reading

Zelboraf® Active in Hairy Cell Leukemia (September 24, 2015)

The targeted agent, Zelboraf® (vemurafenib), which is approved for the treatment of melanoma, provided high anti-cancer activity among patients with hairy-cell leukemia that had stopped responding to... Continue Reading

September Is National Blood Cancer Awareness Month (September 5, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of blood cancer educational programs for national blood cancer awareness month. As the month of September brings blood... Continue Reading

Caring for Yourself During Chemotherapy for Leukemia: How to Manage Hair Loss, Dry Skin, and Brittle Nails (June 3, 2012)

Chemotherapy can be effective treatment for cancer but may also cause physical side effects that may be uncomfortable and affect your appearance. These side effects, however, are manageable. Hair Loss Hair... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients.... Continue Reading

September Is National Leukemia and Lymphoma Awareness Month (August 28, 2009)

As the month of September brings leukemia and lymphoma into focus, it’s time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention, treatment... Continue Reading

Patients with Hairy Cell Leukemia Have an Increased Risk of Second Cancers (February 7, 2007)

Patients with Hairy Cell Leukemia Have an Increased Risk of Second Cancers According to an article recently published in the Journal of the National Cancer Institute, patients with hairy cell leukemia... Continue Reading

Vaccine Highly Effective in Hairy Cell Leukemia (September 19, 2005)

Vaccine Highly Effective in Hairy Cell Leukemia According to a recent article published in the Journal of Clinical Oncology, the vaccine referred to as recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) is... Continue Reading

Simple Diagnostic Test for Hairy Cell Leukemia (August 30, 2004)

Simple Diagnostic Test for Hairy Cell Leukemia According to a recent article published in The Lancet, a marker identified by gene profiling referred to as Annexin A1 (ANXA1) can help distinguish hairy... Continue Reading

Rituxan® Promising for Hairy Cell Leukemia (December 1, 2003)

Rituxan® Promising for Hairy Cell Leukemia According to a recent article published in the journal Blood, Rituxan® (rituximab) produces high anti-cancer response rates in patients... Continue Reading

BL22 Immunotoxin Produces High Responses in Hairy Cell Leukemia (February 21, 2002)

BL22 Immunotoxin Produces High Responses in Hairy Cell Leukemia Results from an early-phase clinical trial evaluating an innovative form of treatment involving a toxin from bacteria has demonstrated... Continue Reading

High Response Rates to Immunotoxin in Hairy Cell Leukemia (February 21, 2002)

High Response Rates to Immunotoxin in Hairy Cell Leukemia An innovative form of treatment involving a toxin from bacteria has demonstrated high anti-cancer activity in patients with hairy cell leukemia... Continue Reading

High Survival Rates Achieved in Patients with Hairy Cell Leukemia Treated with Pentostatin (February 21, 2002)

High Survival Rates Achieved in Patients with Hairy Cell Leukemia Treated with Pentostatin According to results from a recent clinical study published in the journal Blood, patients with hairy cell... Continue Reading

Rituxan®: An Effective New Treatment in Hairy Cell Leukemia (February 21, 2002)

Rituxan®: An Effective New Treatment in Hairy Cell Leukemia Rituxan®, the first monoclonal antibody approved by the FDA, may be of significant benefit for patients with hairy cell leukemia... Continue Reading

Deoxycoformycin Is Effective Against Hairy Cell Leukemia (February 21, 2002)

Deoxycoformycin Is Effective Against Hairy Cell Leukemia Deoxycoformycin is a drug often used to help decrease symptoms and prolong survival in persons with hairy cell leukemia. A recent study confirms... Continue Reading

New Immunotoxin Treatment for Hairy Cell Leukemia and Other Cancers (February 21, 2002)

New Immunotoxin Treatment for Hairy Cell Leukemia and Other Cancers Hairy cell leukemia is a slow-growing lymphoid leukemia of B-cell type that is usually treated with alfa interferon, 2-chlorodeoxyadenosine... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS